Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve
Status:
Recruiting
Trial end date:
2025-10-30
Target enrollment:
Participant gender:
Summary
This study was a prospective randomized controlled trial. Patients aged <35 years with
decreased clinical reserve function (AFC<5, FSH > 10miu/ml, AMH < 1.1μg/L) and receiving
IVF/ICSI assisted ovulation induction in our hospital were included in this study. After
randomization using Excel(Microsoft Corporation, Albuquerque, NM, USA), these patients were
divided into two groups. Group A was the experimental group, which was treated with growth
hormone for 3 months (2 units per day) before IVF/ICSI. Group B was the control group, which
was directly assisted by IVF/ICSI.